Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poziotinib in Metastatic/Recurrent HNSCC
NCT02216916Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Aug 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of poziotinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Yonsei University. Status: unknown.
02
Drugs
poziotinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02216916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216916.